Patents Assigned to Skua Investments Limited
  • Patent number: 5665700
    Abstract: A Pharmaceutical formulation comprises a biologically active material such as insulin, erythropoietin, calcitonin and growth hormone, and, associated with it, a phospholipid for forming a material which participates in the alpha-glycerol or other pathways for the formation of lecithins which are found in the intestinal epithelial cell. Biologically active protein orally administered in such a formulation are bioavailable and bioactive.
    Type: Grant
    Filed: August 15, 1994
    Date of Patent: September 9, 1997
    Assignee: Skua Investments Limited
    Inventors: Young W. Cho, Michael John Flynn, Thomas Smith Shepherd